The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis

Bryna S. M. Chow, Christine Koulis, Pooja Krishnaswamy, Ulrike M. Steckelings, Thomas Unger, Mark E. Cooper, Karin A. Jandeleit-Dahm, Terri J. Allen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1778-1790
JournalDiabetologia
Volume59
Issue number8
DOIs
Publication statusPublished - Aug 2016

Keywords

  • Angiotensin II
  • AT(2) receptor
  • Atherosclerosis
  • Compound 21
  • Diabetes

Cite this

Chow, B. S. M., Koulis, C., Krishnaswamy, P., Steckelings, U. M., Unger, T., Cooper, M. E., Jandeleit-Dahm, K. A., & Allen, T. J. (2016). The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis. Diabetologia, 59(8), 1778-1790. https://doi.org/10.1007/s00125-016-3977-5